Decreased nitric oxide bioavailability in a mouse model of Fabry disease.
暂无分享,去创建一个
[1] P. Luna,et al. [Fabry disease]. , 2009, Anais brasileiros de dermatologia.
[2] James L. Park,et al. VASCULAR DYSFUNCTION IN THE α‐GALACTOSIDASE A‐KNOCKOUT MOUSE IS AN ENDOTHELIAL CELL‐, PLASMA MEMBRANE‐BASED DEFECT , 2008, Clinical and experimental pharmacology & physiology.
[3] S. Pennathur,et al. Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage , 2008, Reviews in Endocrine and Metabolic Disorders.
[4] J. Shayman,et al. Chapter 13 – Fabry Disease , 2008 .
[5] J. Shayman,et al. Caveolin-associated Accumulation of Globotriaosylceramide in the Vascular Endothelium of α-Galactosidase A Null Mice* , 2007, Journal of Biological Chemistry.
[6] S. Pennathur,et al. Oxidative stress and endothelial dysfunction in vascular disease , 2007, Current diabetes reports.
[7] M. Verhaar,et al. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. , 2007, Current pharmaceutical design.
[8] S. Pennathur,et al. Mechanisms for oxidative stress in diabetic cardiovascular disease. , 2007, Antioxidants & redox signaling.
[9] D. Sillence,et al. Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry , 2007, Journal of Inherited Metabolic Disease.
[10] R. Dwek,et al. Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment , 2007, Journal of Inherited Metabolic Disease.
[11] J. Hancock,et al. Biogenesis of caveolae: a structural model for caveolin-induced domain formation , 2006, Journal of Cell Science.
[12] W. Mckenna,et al. Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with α galactosidase A , 2005, Heart.
[13] J. Shayman,et al. An in vitro model of Fabry disease. , 2005, Journal of the American Society of Nephrology : JASN.
[14] J. Williamson,et al. Reactive Carbonyls and Polyunsaturated Fatty Acids Produce a Hydroxyl Radical-like Species , 2005, Journal of Biological Chemistry.
[15] J. Shayman,et al. &agr;-Galactosidase A Deficiency Accelerates Atherosclerosis in Mice With Apolipoprotein E Deficiency , 2005, Circulation.
[16] J. Shayman,et al. Src Kinase Mediates the Regulation of Phospholipase C-γ Activity by Glycosphingolipids* , 2003, Journal of Biological Chemistry.
[17] Steven M Holland,et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. , 2003, The Journal of clinical investigation.
[18] A. Abe,et al. Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. , 2003, Journal of the American Society of Nephrology : JASN.
[19] J. Shayman,et al. Src kinase mediates the regulation of phospholipase C-gamma activity by glycosphingolipids. , 2003, The Journal of biological chemistry.
[20] M. Goligorsky,et al. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. , 2002, American journal of physiology. Renal physiology.
[21] G. Pastores,et al. Anderson-Fabry Disease: Extrarenal, Neurologic Manifestations , 2002 .
[22] P. Shaul. Regulation of endothelial nitric oxide synthase: location, location, location. , 2002, Annual review of physiology.
[23] M. Gladwin,et al. Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy , 2001, Circulation.
[24] K. Litwak,et al. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. , 2001, The Journal of clinical investigation.
[25] E. Jackson,et al. Effects of Estradiol and Its Metabolites on Glomerular Endothelial Nitric Oxide Synthesis and Mesangial Cell Growth , 2001, Hypertension.
[26] A. Abe,et al. Use of sulfobutyl ether beta-cyclodextrin as a vehicle for D-threo-1-phenyl-2-decanoylamino-3-morpholinopropanol-relat ed glucosylceramide synthase inhibitors. , 2000, Analytical biochemistry.
[27] M. Lisanti,et al. A Molecular Dissection of Caveolin-1 Membrane Attachment and Oligomerization , 2000, The Journal of Biological Chemistry.
[28] A. Kulkarni,et al. Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation. , 2000, The Journal of clinical investigation.
[29] J. Shayman,et al. Caveolar structure and protein sorting are maintained in NIH 3T3 cells independent of glycosphingolipid depletion. , 2000, Archives of biochemistry and biophysics.
[30] S. Pennathur,et al. Mass Spectrometric Quantification of 3-Nitrotyrosine, ortho-Tyrosine, and o,o′-Dityrosine in Brain Tissue of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated Mice, a Model of Oxidative Stress in Parkinson's Disease* , 1999, The Journal of Biological Chemistry.
[31] M. Lisanti,et al. The Membrane-spanning Domains of Caveolins-1 and -2 Mediate the Formation of Caveolin Hetero-oligomers , 1999, The Journal of Biological Chemistry.
[32] A. Abe,et al. Improved inhibitors of glucosylceramide synthase. , 1992, The Journal of biological chemistry.
[33] K. Pritchard,et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] I. Pastan,et al. alpha-Galactosidase A deficient mice: a model of Fabry disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Nerem,et al. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. , 1996, Circulation research.
[36] G. Garcı́a-Cardeña,et al. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. , 1996, Biochemistry.
[37] T. Michel,et al. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] H. Ischiropoulos,et al. Oxidative chemistry of peroxynitrite. , 1994, Methods in enzymology.
[39] T. Michel,et al. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.